Macclesfield, United Kingdom

Peter Soderman

USPTO Granted Patents = 10 


Average Co-Inventor Count = 5.8

ph-index = 5

Forward Citations = 45(Granted Patents)


Location History:

  • Sodertalje, SE (2009)
  • Cheshire, GB (2015)
  • Macclesfield, GB (2014 - 2019)

Company Filing History:


Years Active: 2009-2019

Loading Chart...
Loading Chart...
10 patents (USPTO):Explore Patents

Title: The Innovative Contributions of Peter Soderman

Introduction

Peter Soderman is a notable inventor based in Macclesfield, GB. He has made significant contributions to the field of pharmaceuticals, particularly in the development of compounds that serve as BACE inhibitors. With a total of 10 patents to his name, his work is crucial in addressing various cognitive impairments and related pathologies.

Latest Patents

One of Peter Soderman's latest patents involves compounds and their use as BACE inhibitors. This invention relates to compounds of formula (I) and their pharmaceutical compositions. The therapeutic methods outlined in this patent aim to treat and prevent Aβ-related pathologies, including Down's syndrome and β-amyloid angiopathy. Additionally, it addresses disorders associated with cognitive impairment, such as mild cognitive impairment (MCI), Alzheimer's disease, and various forms of dementia. The implications of his work extend to neurodegeneration associated with diseases like Alzheimer's and Parkinson's disease.

Career Highlights

Peter Soderman is currently employed at AstraZeneca AB, where he continues to innovate in the pharmaceutical sector. His extensive research and development efforts have positioned him as a key figure in the fight against cognitive decline and related disorders.

Collaborations

Peter has collaborated with talented coworkers, including Sofia Karlstrom and Liselotte Ohberg. Their combined expertise contributes to the advancement of therapeutic solutions in the pharmaceutical industry.

Conclusion

Peter Soderman's innovative work in developing BACE inhibitors showcases his commitment to improving health outcomes for individuals affected by cognitive impairments. His contributions are vital in the ongoing battle against neurodegenerative diseases.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…